Advertisement
Screener

FRESENIUS MEDICAL CARE AG (FMS) Business Combination, Consideration Transferred

2.8 / 5 stars · 68/120 Roast Me

FRESENIUS MEDICAL CARE AG Business Combination, Consideration Transferred

FRESENIUS MEDICAL CARE AG (FMS) reported Business Combination, Consideration Transferred of $443.34 million for the 12-month period ending 2016-12-31, per its 20-F filed 2017-02-22.

Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred

us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2017-02-22

  • FRESENIUS MEDICAL CARE AG business combination, consideration transferred for the quarter ending 2016-12-31 was $184.61M, a 389.93% increase year-over-year.
  • FRESENIUS MEDICAL CARE AG business combination, consideration transferred for the quarter ending 2016-09-30 was $469.76M, a 253.37% increase year-over-year.
  • FRESENIUS MEDICAL CARE AG business combination, consideration transferred for the quarter ending 2016-06-30 was -$152.99M.
  • FRESENIUS MEDICAL CARE AG business combination, consideration transferred for the quarter ending 2016-03-31 was -$58.03M.
Period endBusiness Combination, Consideration Transferred 3 monthBusiness Combination, Consideration Transferred 3 month as first filedBusiness Combination, Consideration Transferred 6 monthBusiness Combination, Consideration Transferred 9 monthBusiness Combination, Consideration Transferred 9 month as first filedBusiness Combination, Consideration Transferred 12 monthBusiness Combination, Consideration Transferred 12 month as first filed
2016-12-31$184.61M
derived: 20-F 12 month − 6-K 9 month · filed 2017-02-22
$654.36M
derived: sum of 2 quarters · filed 2017-02-22
$501.37M
derived: sum of 3 quarters · filed 2017-02-22
$443.34M
20-F · filed 2017-02-22
2016-09-30$469.76M
derived: 6-K 9 month − 6-K 6 month · filed 2016-10-27
$316.76M
derived: sum of 2 quarters · filed 2016-10-27
$258.73M
6-K · filed 2016-10-27
$296.41M
derived: sum of 4 quarters · filed 2017-02-22
2016-06-30-$152.99M
derived: 6-K 6 month − 6-K 3 month · filed 2016-08-02
-$211.02M
6-K · filed 2016-08-02
-$173.34M
derived: sum of 3 quarters · filed 2017-02-22
-$40.41M
derived: sum of 4 quarters · filed 2017-02-22
2016-03-31-$58.03M
6-K · filed 2016-05-03
-$20.35M
derived: sum of 2 quarters · filed 2017-02-22
$112.59M
derived: sum of 3 quarters · filed 2017-02-22
$112.59M
derived: sum of 4 quarters · filed 2017-02-22
2015-12-31$37.68M
derived: 20-F 12 month − 6-K 9 month · filed 2017-02-22
$170.62M
derived: sum of 2 quarters · filed 2017-02-22
$170.62M
derived: sum of 3 quarters · filed 2017-02-22
$103.34M
20-F · filed 2017-02-22
2015-09-30$132.94M
derived: 6-K 9 month − 6-K 6 month · filed 2016-10-27
$132.94M
derived: sum of 2 quarters · filed 2016-10-27
$65.66M
6-K · filed 2016-10-27
-$65.66M
6-K · filed 2015-10-29
$2.55B
derived: sum of 4 quarters · filed 2017-02-22
2015-06-30$0.00
derived: 6-K 6 month − 6-K 3 month · filed 2016-08-02
-$67.27M
6-K · filed 2016-08-02
$2.42B
derived: sum of 3 quarters · filed 2017-02-22
2015-03-31-$67.27M
6-K · filed 2016-08-02
-$14.51M
6-K · filed 2016-05-03
$2.42B
derived: sum of 2 quarters · filed 2017-02-22
2014-12-31$2.49B
derived: 20-F 12 month − 6-K 9 month · filed 2017-02-22
$1.61B
20-F · filed 2017-02-22
-$1.61B
20-F · filed 2015-02-25
2014-09-30-$874.22M
6-K · filed 2015-10-29
2013-12-31$294.85M
20-F · filed 2016-02-24
-$294.85M
20-F · filed 2015-02-25
2012-12-31-$2.04B
20-F · filed 2015-02-25